Clinical Trials
2 trialsNCT05583409 2022-10-17
SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC
Tongji Hospital
Phase NA Unknown
NCT04816838 2021-08-25
A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR Mutations
Yonsei University
Phase NA Unknown